Safety and efficiency of peanut oral immunotherapy in preschool children with slow up-dosing and low maintenance dosing: a randomised controlled trial.

Lancet Reg Health Eur · 2026 · PMC13330259 · PMID 42403919

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A large international multi-center trial of approximately 550 participants—most of whom were aged 4–17 years—showed a trend towards better outcomes in younger participants.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.